Fish Oil for Eczema: What the Trials Actually Tested

Fish oil is not an established eczema treatment. Small studies have reported benefits, but the American Academy of Dermatology describes inconsistent results for oil supplements. A positive trial of DHA or a mixed supplement does not prove that an ordinary fish-oil capsule will improve eczema.

The evidence below concerns atopic dermatitis. Research doses describe what investigators tested; they are not instructions for self-treatment.

American Academy of Dermatology: oils and eczema · Original adult DHA trial, 2008 · Original pediatric combination trial, 2024 · Sources checked September 19, 2026.

Fish oil, EPA, and DHA are different label quantities

EPA means eicosapentaenoic acid; DHA means docosahexaenoic acid. These omega-3 fatty acids are components of fish oil, not another name for the entire oil.

NIH gives an illustrative supplement containing 1,000 mg of fish oil but only 180 mg of EPA and 120 mg of DHA, while noting that formulations vary widely. The combined EPA and DHA in that example is 300 mg: 180 + 120. A front-label fish-oil quantity therefore cannot be read as the dose of either active fatty acid.

NIH: omega-3 fatty acids · Sources checked September 19, 2026.

What did the adult DHA trial find?

A randomized pilot trial published in 2008 studied adults aged 18–40 with atopic eczema. The intervention was 5.4 g of DHA daily for eight weeks, compared with an equal-energy saturated-fat control.

Reported SCORAD eczema-severity scores changed from 37.0 to 28.5 in the DHA group and from 35.4 to 33.4 in the control group. The authors reported a significant improvement within the DHA group and called for confirmation in a larger study.

That within-group finding does not, by itself, establish a statistically significant difference between treatments. Nor does a concentrated DHA protocol establish the effect of a retail product containing a different EPA-to-DHA mixture. The research dose was DHA, not total fish oil.

Original adult DHA trial, 2008 · Sources checked September 19, 2026.

The newer children’s study tested a combination

A 2024 placebo-controlled trial analyzed data from 52 children, with 26 in each group. The active product, Mega Kid, combined omega-3 fatty acids from fish oil with gamma-linolenic acid (GLA) from blackcurrant seed oil and vitamin D.

After four months, the active group’s median SCORAD decreased from 42 to 25. These are that group’s before-and-after values, not the size of an advantage over placebo. The paper also reported improvements in itch, sleep, and family quality of life.

The authors interpreted the specific combination positively. Because the ingredients were given together, this design cannot identify how much of any benefit came from fish oil alone. Removing GLA and vitamin D from the description would change the intervention being discussed.

Original pediatric combination trial, 2024 · Sources checked September 19, 2026.

Why the positive findings have not settled the question

A Cochrane review published in 2012 found a possible modest benefit in small fish-oil studies, but highlighted the number of outcomes examined and the need for a much larger, convincingly positive trial. It did not find convincing evidence to recommend dietary supplements for established eczema.

That review searched the main literature through 2010 and trial registers through 2011. It cannot evaluate the later pediatric combination trial. Its conclusion belongs beside newer evidence, with its date visible.

The AAD’s public guidance likewise describes inconsistent results for oils including fish oil: some studies suggested benefit, while most found none. A promising individual study and a cautious recommendation can therefore coexist; they answer different questions about how much evidence is sufficient.

Cochrane review, 2012 · American Academy of Dermatology: oils and eczema · Sources checked September 19, 2026.

Cod liver oil and medication interactions need separate attention

NIH notes that cod liver oil supplies vitamins A and D as well as omega-3s. It is therefore not interchangeable with a product chosen solely for EPA and DHA.

Reported omega-3 supplement side effects include heartburn, nausea, and diarrhea. NIH also identifies possible interactions with anticoagulants such as warfarin and advises discussing interactions with a healthcare professional. The AAD advises consulting a child’s dermatologist before adding supplements.

NIH: omega-3 fatty acids · American Academy of Dermatology: oils and eczema · Sources checked September 19, 2026.

Reviewed September 19, 2026. Educational analysis; not individualized medical advice.